Description

Erlocip 150mg (Erlotinib) – Effective Targeted Therapy for Non-Small Cell Lung Cancer and Pancreatic Cancer

Erlocip 150mg is a prescription targeted anticancer medicine formulated with Erlotinib 150mg, an active ingredient widely used for the treatment of specific types of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib belongs to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) class of medicines. It works by inhibiting EGFR activity, helping slow the growth and spread of cancer cells while reducing tumor progression.

Erlocip 150mg is commonly prescribed for the treatment of EGFR mutation-positive metastatic non-small cell lung cancer and, in combination with gemcitabine, for locally advanced, unresectable, or metastatic pancreatic cancer. Because treatment requirements vary between patients, Erlocip 150mg should only be used under the supervision of a qualified healthcare professional.

• Key Features

1. Contains Erlotinib 150mg per tablet
2. Prescription-only targeted anticancer medication
3. Oral tablet for convenient once-daily administration
4. EGFR tyrosine kinase inhibitor (TKI)
5. Used for EGFR mutation-positive non-small cell lung cancer and pancreatic cancer
6. Manufactured under quality pharmaceutical standards

How to Take Erlocip 150mg

For the best therapeutic effect, take Erlocip 150mg exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water.

It is generally recommended to take Erlocip on an empty stomach, at least 1 hour before or 2 hours after meals. Take the medicine at the same time each day. Do not crush, chew, or split the tablet unless advised by your doctor.

Never change the prescribed dose or discontinue treatment without consulting your healthcare provider.

• General Dosage Reference

Medical Condition	Recommended Adult Dose
EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)	150mg orally once daily
Pancreatic Cancer (with Gemcitabine)	100mg orally once daily or as directed by the physician
Other Approved Uses	As prescribed by the treating oncologist

The exact dosage should always be determined by your healthcare provider based on the type of cancer, liver function, concurrent medications, treatment response, and overall medical condition.

Safety Information

Before starting Erlocip 150mg, inform your healthcare provider if you have liver disease, kidney disease, lung disease, gastrointestinal disorders, bleeding disorders, eye disorders, or any known allergy to Erlotinib.

Women who are pregnant, planning pregnancy, or breastfeeding should consult their doctor before using this medicine. Erlotinib may cause fetal harm. Effective contraception is recommended during treatment and for the period advised after the final dose.

Tell your healthcare provider about all prescription medicines, over-the-counter drugs, vitamins, herbal supplements, and tobacco use, as smoking may reduce the effectiveness of Erlotinib and certain medicines may interact with treatment.

Most people tolerate Erlocip 150mg well when taken as prescribed. However, some individuals may experience:

1. Skin rash
2. Diarrhea
3. Nausea
4. Fatigue
5. Loss of appetite
6. Dry skin
7. Mouth sores
8. Eye irritation
9. Elevated liver enzymes

Seek immediate medical attention if you experience severe breathing problems, persistent diarrhea, severe skin reactions, vision changes, severe abdominal pain, unusual bleeding, signs of liver injury, or serious allergic reactions.

Product Specifications

Specification	Information
Brand	Erlocip
Generic Name	Erlotinib
Active Ingredient	Erlotinib Hydrochloride
Strength	150mg
Dosage Form	Oral Tablet
Drug Class	EGFR Tyrosine Kinase Inhibitor (TKI)
Route of Administration	Oral
Prescription Status	Prescription Required
Storage	Store below 25°C in a cool, dry place away from moisture and direct sunlight.

Frequently Asked Questions

Can Erlocip 150mg be taken with food?

No. Erlocip 150mg should generally be taken on an empty stomach, at least 1 hour before or 2 hours after meals, unless your healthcare provider advises otherwise.

How quickly does Erlocip 150mg start working?

Erlotinib begins blocking EGFR activity soon after absorption, but the time to noticeable clinical improvement varies depending on the cancer type, stage, and individual response to treatment.

Is Erlocip 150mg chemotherapy?

No. Erlocip 150mg is a targeted therapy (EGFR tyrosine kinase inhibitor) and is different from conventional chemotherapy.

Can I purchase Erlocip 150mg online?

Availability depends on your country’s regulations. A valid prescription may be required before purchasing Erlocip 150mg online.

What should I do if I miss a dose?

Take the missed dose as soon as you remember if it is not close to your next scheduled dose. If it is almost time for your next dose, skip the missed dose and continue your regular schedule. Do not take two doses together. Consult your healthcare provider if you are unsure.